Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Reunion Neuroscience Inc C.FTRP


Primary Symbol: T.REUN

Reunion Neuroscience Inc. is engaged in the psychedelic drug development company that provides therapeutic solutions for mental health conditions by developing serotonin receptor agonist compounds. The Company is developing the advancement of synthetic molecules targeting serotonin 5HT2A receptors. The Company’s products include RE104 and RE200. The Company’s lead asset, RE-104, which is a psychedelic drug being developed for post-partum and treatment resistant depression as a potential fast-acting antidepressant with durable efficacy. The RE104 as a potentially fast-acting treatment for the key indications of postpartum and treatment resistant depression. The Company is developing the RE200 series, which includes compounds with potential for more selective serotonin receptor activity with reduced psych activity for potential use in more chronic treatment paradigms and indications. The Company is focused on the research and development of its RE200 molecule group.


TSX:REUN - Post by User

Comment by evilballson Nov 29, 2021 1:19pm
693 Views
Post# 34176425

RE:1 million in sales ,400 million market cap , ah ok

RE:1 million in sales ,400 million market cap , ah ok Facebookl was a massive success on ery little revenue for years.  All you have to do is look at the studies. Read the facts. Hear the testimonials. Pyschelics are groundbreaking therapy for many mental illnesses that have been resistant to any other type of therapy.  That is what you are investing in.  The only gamble on this company is timing.  When is the time for Field Trip's prie action to break out of this range bound action? Its not an if but a when and the numbers would be the last thing I would worry about in the first couple years of expansion. You build it, they will come. 
<< Previous
Bullboard Posts
Next >>